Completed PHASE4 INTERVENTIONAL NCT00186836

Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients

Efficacy of Combined Hepatitis A and Hepatitis B (Twinrix) Vaccine Compared With Hepatitis B Vaccine Alone in Providing Seroprotection Against Hepatitis B in Hemodialysis Patients

Sponsor: St. Joseph's Health Care London

Conditions Hepatitis B

Interventions Engerix-B and Twinrix

Updated 5 times since 2017 Last updated: Apr 19, 2007 Started: Nov 30, 2004 Completion: Nov 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00186836, this PHASE4 trial focuses on Hepatitis B and remains completed. Sponsored by St. Joseph's Health Care London, it has been updated 5 times since 2004, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Joseph's Health Care London

Data source: St. Joseph's Healthcare Hamilton

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada